Evidence against a Role for SV40 in Human Mesothelioma
Open Access
- 1 April 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (7) , 2602-2609
- https://doi.org/10.1158/0008-5472.can-04-2461
Abstract
SV40 has been implicated in the etiology of 40% to 60% of human mesotheliomas. These studies could have important medical implications concerning possible sources of human infection and potential therapies if human tumors are induced by this agent. We did PCR-based analysis to detect SV40 large T antigen DNA in human mesotheliomas. None of 69 tumors in which a single copy gene was readily amplified contained detectable SV40 large T antigen sequences. Under these conditions, it was possible to detect one copy of integrated SV40 DNA per cell in a mixture containing a 5,000-fold excess of normal cells using formalin-fixed preparations. Kidney, a known reservoir of SV40 in monkeys, from some of these individuals were also negative for SV40 large T antigen sequences. A subset of mesotheliomas was analyzed for SV40 large T antigen expression by immunostaining with a highly specific SV40 antibody. These tumors as well as several human mesothelioma cell lines previously reported to contain SV40 large T antigen were negative for detection of the virally encoded oncoprotein. Moreover, mesothelioma cell lines with wild-type p53 showed normal p53 function in response to genotoxic stress, findings inconsistent with p53 inactivation by the putative presence of SV40 large T antigen. Taken together, these findings strongly argue against a role of SV40 by any known transformation mechanism in the etiology of the majority of human malignant mesotheliomas.Keywords
This publication has 31 references indexed in Scilit:
- Poliovirus Vaccination during Pregnancy, Maternal Seroconversion to Simian Virus 40, and Risk of Childhood CancerAmerican Journal of Epidemiology, 2004
- Case-Control Study of Cancer among US Army Veterans Exposed to Simian Virus 40-contaminated Adenovirus VaccineAmerican Journal of Epidemiology, 2004
- Simian virus 40 (SV40) and human cancer: a review of the serological dataReviews in Medical Virology, 2004
- Simian Virus 40 Infection of HumansJournal of Virology, 2003
- Association of SV40 with human tumoursSeminars in Cancer Biology, 2001
- SV40 and the pathogenesis of mesotheliomaSeminars in Cancer Biology, 2001
- The role of the E6-p53 interaction in the molecular pathogenesis of HPVOncogene, 1999
- SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumorsOncogene, 1998
- High titers of antibodies to two human polyomaviruses, JCV and BKV, correlate with increased frequency of chromosomal damage in human lymphocytesCancer Letters, 1996
- The transforming activity of simian virus 40 large tumor antigenBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1994